Malignant Melanoma: Skin Cancer-Diagnosis, Prevention, and Treatment.
Ahmed B, Qadir MI, Ghafoor S.
Crit Rev Eukaryot Gene Expr. 2020;30(4):291-297. doi: 10.1615/CritRevEukaryotGeneExpr.2020028454.
Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes.
Fusenig NE, Boukamp P.
Mol Carcinog. 1998 Nov;23(3):144-58. doi: 10.1002/(sici)1098-2744(199811)23:3<144::aid-mc3>3.0.co;2-u.
Atypical fibroxanthoma: A malignant tumor of the skin and soft tissue.
Rosenfeld D, Alam M, Van Tine B, Council ML.
J Am Acad Dermatol. 2020 Dec;83(6):e429-e430. doi: 10.1016/j.jaad.2020.07.022. Epub 2020 Jul 15.
Acral Melanoma: A Review of Its Pathogenesis, Progression, and Management.
Kim SH, Tsao H.
Biomolecules. 2025 Jan 14;15(1):120. doi: 10.3390/biom15010120.
A case of cutaneous malignant glomus tumor.
Senff S, Orschulok TP, Lambie DL, Lehane F.
J Cutan Pathol. 2024 Jan;51(1):50-52. doi: 10.1111/cup.14531. Epub 2023 Sep 3.
Isolation and Phenotypic Characterization of Tumor-Infiltrating NK Cells in Skin Carcinoma.
Arjmand B, Hamidpour SK, Tayanloo-Beik A, Arjmand R, Rezaei-Tavirani M, Aghayan H, Rajaeinejad M, Larijani B.
Methods Mol Biol. 2024;2849:215-226. doi: 10.1007/7651_2023_512.
From actinic keratosis to cutaneous squamous cell carcinoma: the key pathogenesis and treatments.
Li Z, Lu F, Zhou F, Song D, Chang L, Liu W, Yan G, Zhang G.
Front Immunol. 2025 Jan 24;16:1518633. doi: 10.3389/fimmu.2025.1518633. eCollection 2025.
[Malignant collision tumor of the skin : Melanoma, squamous cell carcinoma and basal cell carcinoma].
Sterz H, Kendler M, Simon JC, Ziemer M.
Pathologe. 2019 Sep;40(5):534-538. doi: 10.1007/s00292-019-0622-3.
N-Glycosylation in progression of skin cancer.
Tang L, Chen X, Zhang X, Guo Y, Su J, Zhang J, Peng C, Chen X.
Med Oncol. 2019 Apr 29;36(6):50. doi: 10.1007/s12032-019-1270-4.
[Management of malignant wounds].
Kirchberger MC, Erfurt-Berge C.
Z Gerontol Geriatr. 2020 Oct;53(6):572-576. doi: 10.1007/s00391-019-01629-w. Epub 2019 Oct 2.
